Validation of a Brazilian Portuguese Version of the Walking Estimated-Limitation Calculated by History (WELCH)

Cucato, Gabriel Grizzo; Correia, Marília de Almeida; Farah, Breno Quintella; Saes, Glauco Fernandes; Andrade-Lima, Aluísio; Ritti‐Dias, Raphael Mendes; Wolosker, Nelson

doi:10.5935/abc.20160004

Cited by 16 publications

(23 citation statements)

References 25 publications

(34 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Subjective physical function was measured by validated versions of the WIQ (17) and WELCH questionnaire (18). The WIQ assesses self-reported ambulatory ability in 3 domains: walking distance, walking speed, and stair climbing, with each domain scored on a 0 to 100 scale, where 0 represents extreme limitation and 100 represents no difficulties walking long distances, walking rapidly, or climbing 3 stair flights, respectively.…”

Section: Methodsmentioning

confidence: 99%

“…The WIQ assesses self-reported ambulatory ability in 3 domains: walking distance, walking speed, and stair climbing, with each domain scored on a 0 to 100 scale, where 0 represents extreme limitation and 100 represents no difficulties walking long distances, walking rapidly, or climbing 3 stair flights, respectively. The WELCH questionnaire (18) is a four-question questionnaire related to the speed at which the patient walks normally. The WELCH score ranges from 0 to 100, with zero indicating a patient who can only walk for 30 seconds when walking slowly and who usually walks much slower than relatives, friends or people of the same age without PAD.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Relationship between gait speed and physical function in patients with symptomatic peripheral artery disease

Correia¹,

Cucato²,

Lanza³

et al. 2019

Clinics

Self Cite

View full text Add to dashboard Cite

OBJECTIVE:The aim of the study was to analyze the relationship between gait speed and measurements of physical function in patients with symptomatic peripheral artery disease (PAD).METHODS:One hundred sixty-nine patients (age 66.6±9.4 years) with symptomatic PAD were recruited. Usual and fast gait speeds were assessed with a 4-meter walk test. Objective (balance, sit-to-stand, handrip strength, and six-minute walk test) and subjective (WIQ - Walking Impairment Questionnaire and WELCH - Walking Estimated-Limitation Calculated by History) measurements of physical function were obtained. Crude and adjusted linear regression analyses were used to confirm significant associations.RESULTS:Usual and fast gait speeds were significantly correlated with all objective and subjective physical function variables examined (r<0.55, p<0.05). In the multivariate model, usual gait speed was associated with six-minute walking distance (β=0.001, p<0.001), sit-to-stand test score (β=-0.005, p=0.012), and WIQ stairs score (β=0.002, p=0.006) adjusted by age, ankle brachial index, body mass index, and gender. Fast gait speed was associated with six-minute walking distance (β=0.002, p<0.001), WIQ stairs score (β=0.003, p=0.010), and WELCH total score (β=0.004, p=0.026) adjusted by age, ankle brachial index, body mass index, and gender.CONCLUSION:Usual and fast gait speeds assessed with the 4-meter test were moderately associated with objective and subjective measurements of physical function in symptomatic PAD patients.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Relationship between gait speed and physical function in patients with symptomatic peripheral artery disease

Correia¹,

Cucato²,

Lanza³

et al. 2019

Clinics

Self Cite

View full text Add to dashboard Cite

show abstract

“…2,6 It is currently available in different languages and is easy to use in routine practice. 7e9 Correlation of the WELCH score and objective measures of walking capacity range from 0.58 to 0.82, 6,8,9 and it is not impaired by age. 2 To date, the reliability and sensitivity to changes of the WELCH have not been studied extensively.…”

Section: Introductionmentioning

confidence: 99%

Treadmill Measured vs. Questionnaire Estimated Changes in Walking Ability in Patients With Peripheral Artery Disease

Henni

Ammi

Semporé

et al. 2019

European Journal of Vascular and Endovascular Surgery

View full text Add to dashboard Cite

WHAT THIS PAPER ADDS In patients with peripheral artery disease, the Walking Estimated Limitation Calculated by History (WELCH) questionnaire score correlates with the maximum treadmill walking time. Changes in WELCH score tend to decrease more than the objective changes in walking impairment, particularly with a longer a testeretest interval. After revascularisation, a shortlived "honeymoon" (overestimation of the objectively measured change on the treadmill) is observed. For long testeretest intervals, self reported worsening according to the WELCH score should probably be confirmed on the treadmill before a decision to revascularise is taken. Whether other questionnaires estimating walking impairment face the same issue remains to be determined. Objective: Determining the maximum walking time (MWT) using the treadmill test is the gold standard method for evaluating walking capacity and treatment effect in patients with peripheral arterial disease (PAD). However, self reported functional disability is important when assessing quality of life. Changes in the Walking Estimated Limitation Calculated by History (WELCH) questionnaire scores were compared with the MWT. Methods: A cross sectional study was performed in patients with intermittent claudication. The treadmill test (3.2 km/h; 10% gradient) and WELCH questionnaire were administered to all patients for objective evaluation of walking capacity. Given the log normal distribution of these parameters in patients with PAD, a log transformation was applied to the WELCH score (LnW) and maximum walking time (LnT). The responsiveness of the WELCH score was determined using mean changes and correlation coefficients of LnW and LnT changes. The effect of time on the "estimated minus real" (E À R) changes (LnW À change minus LnT À change) was assessed after categorisation of patients into various testeretest intervals. Patients who underwent lower limb revascularisation between the two tests and those who underwent medical treatment only were analysed. Results: Correlation coefficients between LnW and LnT for tests 1 and 2 were r ¼ 0.514 and r ¼ 0.503, respectively (p < .001, for both). Correlation for LnW change vs. LnT change was 0.384 (p < .001). E À R was positive only early after surgery. E À R was negative for all testeretest intervals >1 year in revascularised and non-revascularised patients. Conclusion: Changes in WELCH scores correlated with changes observed on the treadmill in patients with intermittent claudication. For long testeretest intervals, WELCH changes tended to overestimate the worsening of walking impairment as compared with the measured difference observed in both revascularised and non-revascularised patients. A shortlived "honeymoon" (overestimation of the benefit for the shortest testeretest interval) was observed only in revascularised patients.

show abstract

“…A közelmúltban megalkotott WELCH-kérdőívet nemrégiben javasolták új, egyszerű és könnyen alkalmazható eszközként a CI-ben szenvedő betegek járóképességének felmérésére. A WELCH-kérdőívet már több nyelven validálták [23,31], Magyarországon a SHERIFFvizsgálatban alkalmaztuk először [19]. A WELCH-pontszám a 3 hónapos CIL-kezelést követően szignifikánsan nőtt, az eredmény szignifikáns korrelációt mutatott a mért járástávolságokkal -az erre vonatkozó részletes adatokat illetően utalunk a vizsgálat korábbi publikációjára [31].…”

Section: Eredeti Közleményunclassified

“…A WELCH-kérdőívet már több nyelven validálták [23,31], Magyarországon a SHERIFFvizsgálatban alkalmaztuk először [19]. A WELCH-pontszám a 3 hónapos CIL-kezelést követően szignifikánsan nőtt, az eredmény szignifikáns korrelációt mutatott a mért járástávolságokkal -az erre vonatkozó részletes adatokat illetően utalunk a vizsgálat korábbi publikációjára [31]. A WELCH-kérdőív alapján mért járóképesség -a DM-betegcsoportot jellemző, korábban említett tényezők miatt -a DM-betegekben kisebb volt.…”

Section: Eredeti Közleményunclassified

A cilostazol diabeteses betegekben is javítja az életminőséget és az alsó végtagi funkcionális kapacitást

Farkas

Járai

2020

View full text Add to dashboard Cite

Absztrakt: Bevezetés: A claudicatio intermittens jelentős negatív hatással van a betegek életminőségére. A különböző revascularisatiós eljárások és a noninvazív orvosi kezelések javíthatják a betegek járását. A cilostazol I.A ajánlással rendelkezik a claudicatio intermittens kezelésére. Célkitűzés: Vizsgálatunk célja a 3 hónapos cilostazolkezelésnek az egészséggel kapcsolatos életminőségre és az alsó végtag funkcionális kapacitására gyakorolt hatásának értékelése a klinikai gyakorlatban, claudicatio intermittensben szenvedő diabeteses (DM) és nem diabeteses (NDM) betegek körében. Módszer: A tanulmány multicentrikus, beavatkozással nem járó vizsgálat, amelybe 812, ambuláns kezelés alatt álló, perifériás verőérbetegségben szenvedő beteg (Fontaine II. stádium, átlagéletkor: 67,17 év, férfi/nő: 58,25/41,75%, 318 diabeteses) került beválasztásra, akik cilostazolkezelést kaptak (50 vagy 100 mg naponta kétszer) 3 hónapig. Az életminőséget az EQ-5D-3L-kérdőívvel, a funkcionális kapacitást a WELCH-kérdőívvel értékeltük. A fájdalommentes és maximális járástávolságnak, valamint a boka-kar indexnek a mérése megtörtént a vizsgálat indulásakor és a 3 hónapos kezelés után. Eredmények: A vizsgálat befejezése után az EQ-5D-index javult (kiindulási érték: NDM –0,45 ± 0,22, DM –0,48 ± 0,23, 3. hónap: –0,24 ± 0,18, –0,27 ± 0,19; p<0,0001), és a WELCH-pontszám szintén szignifikánsan nőtt (kiindulási érték: NDM 20 ± 14, DM 18 ± 14; 3. hónap: 33 ± 19, 29 ± 16; p<0,0001) mindkét betegcsoportban. Mind a fájdalommentes, mind a maximális járástávolság nőtt: NDM 59,2% (medián: 50,0%), 46,58 (medián: 40,51%), és DM 42,85% (medián: 43,33%), 41,61% (medián: 34,68%) (p<0,001). Következtetés: 3 hónapos cilostazolkezelés javította az életminőséget és az alsó végtagi funkcionális kapacitást claudicatio intermittensben szenvedő betegekben, diabetes esetén is. A WELCH-kérdőív hasznos eszköznek bizonyult a klinikai gyakorlatban a claudicatio kezelése során a járóképesség értékelésére. Orv Hetil. 2020; 161(38): 1637–1645.

show abstract

Validation of a Brazilian Portuguese Version of the Walking Estimated-Limitation Calculated by History (WELCH)

Cited by 16 publications

References 25 publications

Relationship between gait speed and physical function in patients with symptomatic peripheral artery disease

Relationship between gait speed and physical function in patients with symptomatic peripheral artery disease

Treadmill Measured vs. Questionnaire Estimated Changes in Walking Ability in Patients With Peripheral Artery Disease

A cilostazol diabeteses betegekben is javítja az életminőséget és az alsó végtagi funkcionális kapacitást

Contact Info

Product

Resources

About